Healthcare professionals and people all over the world are embracing minimally invasive therapies and image-guided procedures more and more. From being a traditional diagnostic modality for OB/GYN imaging, ultrasonography has undergone a considerable transition to become a therapeutic approach for kidney stones, malignancies, and other clinical disorders. These initiatives will likely create new opportunities for manufacturers in contrast media market to increase their revenue.